|
|
| | The trial balances as at 31 March 2016 |
| | NZL | | NIL | | SIL |
| | Dr | Cr | Dr | Cr | Dr | Cr |
| Sales revenue | | 1,400,000 | | 520,000 | | 450,000 |
| Other income | | 136,000 | | 80,000 | | 50,000 |
| Cost of Sales | 300,000 | | 200,000 | | 200,000 |
| Operating expenses | 200,000 | | 240,000 | | 100,000 |
| Income tax expense | 540,000 | | 50,000 | | 80,000 |
| Dividends declared | 400,000 |
| Share Capital | | 8,000,000 | | 2,000,000 | | 1,600,000 |
| Retained earnings (31 March 2015) | | 2,000,000 | | 600,000 | | 800,000 |
| Loans | | 2,400,000 | | 500,000 |
| Accounts payable | | 340,000 | | 80,000 |
| Dividends payable | | 400,000 |
| Land | 4,800,000 | | | | 400,000 |
| Property Plant and Equipment | 3,600,000 | | 2,730,000 | | 920,000 |
| Accumulated depreciation - PPE | | 600,000 | | 500,000 | | 200,000 |
| Investment in NIL | 2,000,000 |
| Investment in SIL | 1,600,000 |
| Cash | 590,000 | | 110,000 | | 200,000 |
| Accounts receivable | 246,000 | | 350,000 | | 400,000 |
| Inventory | 1,000,000 | | 600,000 | | 800,000 |
| | 15,276,000 | 15,276,000 | 4,280,000 | 4,280,000 | 3,100,000 | 3,100,000 |